Nancy Cox, the virologist who directed the Centers for Disease Control and Prevention's influenza division for two decades, died at 77. Her work shaped how the world tracks, predicts, and responds to seasonal and pandemic flu.
Cox led the CDC's influenza division from 2004 to 2024, a period marked by major viral challenges. She oversaw the response to the 2009 H1N1 pandemic, which killed hundreds of thousands globally. She also managed the agency's surveillance systems during repeated avian flu outbreaks and the emergence of new seasonal strains.
Her core mission involved solving a fundamental problem: influenza viruses mutate constantly, making last year's vaccine potentially ineffective this year. Cox built a global network of laboratories and epidemiologists across more than 140 countries to monitor flu evolution in real time. This system allowed researchers to detect dangerous new strains months before they spread widely.
The CDC's influenza division recommends which flu virus strains should be included in annual vaccines. Cox's team analyzed genetic sequences from thousands of flu samples each year, predicting which variants would likely dominate the next season. The work demanded both scientific precision and educated guessing, since vaccine development begins months before flu season arrives.
Cox earned her Ph.D. in microbiology from the University of Iowa. She joined the CDC in 1992 as a postdoctoral fellow and spent her entire career there. Colleagues described her as tireless and collaborative, building trust across international health agencies despite the competitive nature of infectious disease research.
Her influence extended beyond laboratory work. During the COVID-19 pandemic, Cox advised policymakers on respiratory virus transmission. She published more than 300 scientific papers on influenza genetics and epidemiology, many co-authored with international partners she recruited into her network.
The flu remains unpredictable. Some years, vaccines match